• 1. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
• 2. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 3. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 4. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 5. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aniline and substituted anilines

Introduction to (S)-4-(1-Aminoethyl)aniline dihydrochloride (CAS No. 255060-76-5)

(S)-4-(1-Aminoethyl)aniline dihydrochloride (CAS No. 255060-76-5) is a chiral compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is a derivative of aniline, with a unique chiral center at the ethyl group, making it particularly valuable for the development of enantiomerically pure drugs. The dihydrochloride salt form enhances its solubility and stability, which are crucial for various applications in drug discovery and development.

The (S)-4-(1-Aminoethyl)aniline dihydrochloride molecule is characterized by its distinct structural features, including a benzene ring substituted with an aminoethyl group. The presence of the chiral center at the carbon atom adjacent to the amine group imparts specific stereochemical properties to the compound. These properties are essential for its biological activity and interactions with target proteins or receptors.

Recent advancements in synthetic chemistry have led to the development of efficient and scalable methods for the synthesis of (S)-4-(1-Aminoethyl)aniline dihydrochloride. One such method involves the asymmetric reduction of a prochiral ketone using a chiral catalyst, followed by subsequent derivatization steps to form the final product. This approach not only ensures high enantiomeric purity but also reduces the overall cost and environmental impact of the synthesis process.

In the context of medicinal chemistry, (S)-4-(1-Aminoethyl)aniline dihydrochloride has shown promising potential as a lead compound for various therapeutic applications. Studies have demonstrated its ability to modulate specific biological pathways, making it a valuable candidate for drug development. For instance, research has indicated that this compound can interact with certain G protein-coupled receptors (GPCRs), which are key targets for treating neurological disorders and other diseases.

Moreover, (S)-4-(1-Aminoethyl)aniline dihydrochloride has been evaluated in preclinical studies for its pharmacological properties, including its bioavailability, metabolism, and toxicity profiles. These studies have provided valuable insights into its behavior in biological systems and have helped guide further optimization efforts. The compound's favorable pharmacokinetic properties make it an attractive candidate for further clinical investigation.

The therapeutic potential of (S)-4-(1-Aminoethyl)aniline dihydrochloride extends beyond its direct biological activity. It can also serve as a building block for the synthesis of more complex molecules with enhanced therapeutic effects. For example, researchers have explored the use of this compound as a scaffold for designing multi-target drugs that can address multiple aspects of complex diseases such as Alzheimer's disease and cancer.

In addition to its medicinal applications, (S)-4-(1-Aminoethyl)aniline dihydrochloride has found utility in other areas of chemical research. Its unique structural features make it an excellent model compound for studying chiral recognition and enantioselective catalysis. These studies contribute to our understanding of fundamental chemical processes and can lead to the development of new methodologies for synthesizing chiral compounds.

The safety profile of (S)-4-(1-Aminoethyl)aniline dihydrochloride is another critical aspect that has been extensively investigated. Toxicological studies have shown that this compound exhibits low toxicity at therapeutic doses, making it suitable for use in clinical settings. However, like any pharmaceutical agent, it is essential to conduct thorough safety assessments before advancing to human trials.

Recent developments in analytical techniques have also facilitated the characterization and quality control of (S)-4-(1-Aminoethyl)aniline dihydrochloride. High-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR), and mass spectrometry (MS) are commonly used methods to ensure the purity and identity of this compound. These techniques are crucial for maintaining high standards in pharmaceutical manufacturing and research.

In conclusion, (S)-4-(1-Aminoethyl)aniline dihydrochloride (CAS No. 255060-76-5) is a versatile and promising compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features, combined with its favorable pharmacological properties, make it an attractive candidate for further development as a therapeutic agent. Ongoing research continues to uncover new applications and optimize its use in various fields, contributing to advancements in drug discovery and chemical science.

• 17279-30-0(Benzenemethanamine, a-methyl-, hydrochloride (1:1), (aS)-)
• 84499-72-9((1S)-1-(p-tolyl)ethanamine;hydrochloride)
• 1202057-39-3(3-[(1R)-1-aminoethyl]aniline)
• 317830-29-8(3-(1S)-1-Aminoethylaniline)
• 129725-48-0(3-(1-Aminoethyl)aniline)
• 65645-32-1((R)-4-(1-Aminoethyl)benzenamine)
• 13437-79-1(Benzenemethanamine, a-methyl-, hydrochloride)
• 1032149-84-0((1R)-1-(4-ethylphenyl)ethanamine;hydrochloride)
• 65645-33-2((S)-4-(1-Amino-ethyl)-phenylamine)
• 90434-58-5(4-(1-Aminoethyl)-phenylamine)